Oct. 30 2024
Source Page: Equality and Human Rights Mainstreaming Strategy: ConsultationFound: Equality and Human Rights Mainstreaming Strategy: Consultation
Sep. 17 2024
Source Page: Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancerFound: peritoneal cancer (Review of TA611) 1 of 2 Issue date: August 2024 NATIONAL INSTITUTE FOR HEALTH AND
Sep. 04 2024
Source Page: LGBTI Equality Team: FOI releaseFound: LGBTI Equality Team: FOI release
Aug. 08 2024
Source Page: Faricimab for treating visual impairment caused by macular oedema after retinal vein occlusionFound: caused by retinal vein occlusion 1 of 3 Issue date: August 2024 NATIONAL INSTITUTE FOR HEALTH AND
Aug. 29 2024
Source Page: Pembrolizumab for adjuvant treatment of resected non-small-cell lung cancer [ID3907]Found: non -small -cell lung cancer [ID3907] 1 of 2 Issue date: August 2024 NATIONAL INSTITUTE FOR HEALTH AND
Sep. 19 2024
Source Page: Quizartinib for induction, consolidation and maintenance treatment of newly diagnosed FLT3-ITD-positive acute myeloid leukaemiaFound: Quizartinib for induction, consolidation and maintenance treatment of newly diagnosed FLT3-ITD-positive
Oct. 30 2024
Source Page: Osimertinib for maintenance treatment of EGFR mutation-positive locally advanced or unresectable non-small-cell lung cancer after platinum-based chemoradiation ID6223Found: Health Technology Evaluation : Scoping Equality impact assessment for the Health Technology Evaluation
Oct. 01 2024
Source Page: Elacestrant for treating oestrogen receptor-positive, HER2-negative advanced breast cancer with an ESR1 mutation after at least 1 endocrine treatment [ID6225]Found: after endocrine treatment [ID6225] 1 of 3 Issue date: September 2024 NATIONAL INSTITUTE FOR HEALTH AND
Sep. 04 2024
Source Page: Iptacopan for treating paroxysmal nocturnal haemoglobinuriaFound: , and, if so, how ?
Sep. 13 2024
Source Page: Rozanolixizumab for treating antibody-positive generalised myasthenia gravis [ID5092]Found: positive myasthenia gravis [ID5092] 1 of 2 Issue date: September 2024 NATIONAL INSTITUTE FOR HEALTH AND